Impact of Sunflower Seed Oil Massage on Neonatal Mortality & Morbidity in

Status Completed

Clinical Trial Summary

Each year four million babies die during the neonatal period, with the majority occurring in developing countries. Overall, infections account for one-third of all neonatal deaths, with proportions approaching 50% in settings where neonatal mortality rates are high. Infections are predominately due to sepsis, respiratory infections, tetanus, and diarrhea. The investigators long term goal is to identify simple, affordable, and effective interventions that can be delivered at the community level in low-resource settings to reduce neonatal mortality risk due to these infections. The investigators team has conducted research in this area for the past 10 years, with specific focus on newborn vitamin A dosing and topical chlorhexidine antisepsis interventions. Previous community-based research by the investigators group of investigators and others demonstrated that newborn vitamin A dosing can reduce early infant mortality by approximately 20%, and that topical applications of chlorhexidine to the umbilical cord can prevent omphalitis and reduce neonatal mortality risk by 24%. Evidence is growing that neonatal skin plays an important role in protecting the newborn infant from invasive pathogens. Barrier function of the neonatal skin, however, is incomplete in newborn infants, especially those that are pre-term or of low birth weight. Full-body massage of newborns with mustard oil, practiced almost universally (~95%) in communities of south Asia, may further compromise skin barrier function through decreased structural integrity leading to increased trans-epidermal water loss and increased risk of percutaneous penetration by invasive pathogens. Loss of structural integrity is not seen after massage of neonatal skin with alternative topical emollients, including sunflower seed oil. Furthermore, sunflower seed oil has been shown to accelerate recovery of the skin barrier function, improve skin condition, and reduce the risk of both nosocomial infections and neonatal mortality among hospitalized newborns in low-resource settings. The specific hypothesis of this study is that substituting mustard oil with sunflower seed oil for topical applications during full body massage of newborns in the community will reduce neonatal mortality and morbidity by improving overall skin barrier function and reducing exposure to invasive pathogens.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01177111
Study type	Interventional
Source	Johns Hopkins Bloomberg School of Public Health
Contact
Status	Completed
Phase	Phase 3
Start date	November 1, 2010
Completion date	June 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05692128` - Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
Completed	`NCT00942084` - A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)	Phase 1
Completed	`NCT06002295` - A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns	Phase 2
Not yet recruiting	`NCT05114057` - Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI	N/A
Recruiting	`NCT04528251` - Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
Active, not recruiting	`NCT03871491` - Azithromycin-Prevention in Labor Use Study (A-PLUS)	Phase 3
Completed	`NCT03746743` - Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II
Completed	`NCT02386592` - Prevention of Nosocomial Bacteremia Among Zambian Neonates	N/A
Not yet recruiting	`NCT06113653` - Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
Completed	`NCT03199547` - Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death	Phase 3
Completed	`NCT02147327` - Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities	N/A
Completed	`NCT01005589` - CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis	N/A
Completed	`NCT00866567` - Defects in Opsonophagocytosis in Premature Infants	N/A
Completed	`NCT02281890` - Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database	N/A
Suspended	`NCT05156333` - Probiotics and GBS Colonization in Pregnancy	N/A
Recruiting	`NCT05127070` - Evaluating the NeoTree in Malawi and Zimbabwe
Completed	`NCT03755635` - Neonatal Sepsis at Neonatal Intensive Care Units in Ghana	N/A
Completed	`NCT03247920` - Reduction of Intravenous Antibiotics In Neonates	Phase 4
Completed	`NCT03295162` - Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis	Phase 1/Phase 2
Completed	`NCT02954926` - Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of Sunflower Seed Oil Massage on Neonatal Mortality and Morbidity in Nepal — NOMS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms